欧林生物(688319.SH):泰昌集团拟减持不超1.4789%股份
Chengdu Olymvax Biopharmaceuticals Chengdu Olymvax Biopharmaceuticals (SH:688319) 智通财经网·2026-01-27 13:15

Group 1 - The core point of the article is that Olin Bio (688319.SH) announced a plan by Taichang Group to reduce its shareholding due to funding needs, with a maximum reduction of 6 million shares, representing up to 1.4789% of the company's total share capital [1] Group 2 - Taichang Group intends to execute the share reduction through centralized bidding or block trading based on market conditions [1]

Chengdu Olymvax Biopharmaceuticals -欧林生物(688319.SH):泰昌集团拟减持不超1.4789%股份 - Reportify